ETFs
G
GILD
Gilead Sciences Inc
129.16
-0.02-0.02%After Hours: 128.53 -0.63 -0.49%19:56 06/05 EDT
OPEN/PREV CLOSE121.79/121.48
TODAY RANGE121.79-127.37
VOL8.67M
MARKET CAP156.28B
52 WEEK RANGE102.48-156.40
AVG VOL (3M)6.62M
% TURNOVER0.70%
TURNOVER--
P/E (TTM)17.12
% RANGE4.59%
EPS(TTM)7.35
P/E(FORWARD)-43.7049
P/B6.65
BVPS18.93
DIVIDEND3.280
P/S5.31
BETA--
DIV YIELD2.61%
FREE FLOAT MKT CAP156.07B
SHARES OUTSTANDING1.24B
NEXT EARNINGS08/05-08/10
FREE FLOAT1.24B
LOT SIZE1
EX-DATE06/15/2026
News
Press Releases
Financial Reports
Profile
Simply Wall St·9h ago
How Investors Are Reacting To Gilead Sciences (GILD) New HIV Regimen and Liver Disease Milestones
Dow Jones·11h ago
Moderna Inc. Stock Rises 7.9%, Outperforms Peers
Seeking Alpha·13h ago
Kymera, Monte Rosa among gainers as Novartis inks deal for molecular glue drugs
Seeking Alpha·18h ago
Top 10 most oversold S&P 500 stocks
TipRanks·1d ago
Gilead Sciences (GILD) Gets a Buy from Bernstein
Benzinga·2d ago
Gilead And Merck End Trodelvy-Keytruda Lung Cancer Trial
Simply Wall St·2d ago
Gilead Balances Trodelvy Setback With Once Weekly HIV Progress
Seeking Alpha·2d ago
Nurix Therapeutics: 'Strong Buy' Due To Roche Deal And Bexobrutideg Expansions
Same Industry
Name/Symbol
Change%
Price